By Amy Norton
WEDNESDAY, July one, 2020 (HealthDay News) — Researchers are reporting an early action towards an HIV drug that could likely be taken only a couple of periods for each calendar year.
A single injection of the experimental drug, identified as lenacapavir, was in a position to reduce blood concentrations of HIV in a small team of clients. And it was capable of protecting lively concentrations in the blood for extra than six months.
It all raises the possibility of a person day getting an HIV treatment that only